Corcept Therapeutics Inc (CORT)
23.88
+0.56
(+2.40%)
USD |
NASDAQ |
May 01, 16:00
26.00
+2.12
(+8.88%)
After-Hours: 07:44
Corcept Therapeutics Cash from Operations (Quarterly): 5.887M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.887M |
| September 30, 2023 | 52.91M |
| June 30, 2023 | 42.29M |
| March 31, 2023 | 25.96M |
| December 31, 2022 | 33.39M |
| September 30, 2022 | 33.65M |
| June 30, 2022 | 18.04M |
| March 31, 2022 | 35.25M |
| December 31, 2021 | 49.43M |
| September 30, 2021 | 48.70M |
| June 30, 2021 | 44.34M |
| March 31, 2021 | 25.42M |
| December 31, 2020 | 35.07M |
| September 30, 2020 | 30.44M |
| June 30, 2020 | 53.19M |
| March 31, 2020 | 33.27M |
| December 31, 2019 | 48.45M |
| September 30, 2019 | 38.43M |
| June 30, 2019 | 25.56M |
| March 31, 2019 | 23.68M |
| December 31, 2018 | 21.52M |
| September 30, 2018 | 44.50M |
| June 30, 2018 | 15.21M |
| March 31, 2018 | 34.43M |
| December 31, 2017 | 24.88M |
| Date | Value |
|---|---|
| September 30, 2017 | 10.92M |
| June 30, 2017 | 15.57M |
| March 31, 2017 | 9.561M |
| December 31, 2016 | 4.569M |
| September 30, 2016 | 8.935M |
| June 30, 2016 | 1.59M |
| March 31, 2016 | 3.297M |
| December 31, 2015 | 4.163M |
| September 30, 2015 | 0.883M |
| June 30, 2015 | -0.139M |
| March 31, 2015 | -1.777M |
| December 31, 2014 | -1.403M |
| September 30, 2014 | -5.929M |
| June 30, 2014 | -8.984M |
| March 31, 2014 | -11.06M |
| December 31, 2013 | -7.666M |
| September 30, 2013 | -8.602M |
| June 30, 2013 | -9.236M |
| March 31, 2013 | -11.55M |
| December 31, 2012 | -8.742M |
| September 30, 2012 | -9.229M |
| June 30, 2012 | -7.892M |
| March 31, 2012 | -10.16M |
| December 31, 2011 | -6.294M |
| September 30, 2011 | -6.604M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
5.887M
Minimum
Dec 2023
53.19M
Maximum
Jun 2020
35.77M
Average
35.07M
Median
Dec 2020
Cash from Operations (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical Inc | -83.90M |
| Alnylam Pharmaceuticals Inc | -29.80M |
| Catalyst Pharmaceuticals Inc | 55.65M |
| United Therapeutics Corp | 150.70M |
| XOMA Corp | -3.927M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 17.10M |
| Cash from Financing (Quarterly) | 0.766M |
| Free Cash Flow | 126.90M |
| Free Cash Flow Per Share (Quarterly) | 0.0531 |
| Free Cash Flow to Equity (Quarterly) | 5.887M |
| Free Cash Flow to Firm (Quarterly) | 5.887M |
| Free Cash Flow Yield | 4.76% |